MORF logo

Morphic Holding, Inc. Common Stock


MORF: Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.


Show MORF Financials

Consumer Interest
SEC Filings

Recent trades of MORF by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by MORF's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of MORF in WallStreetBets Daily Discussion


Recent insights relating to MORF

CNBC Recommendations

Recent picks made for MORF stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in MORF

Corporate Flights

Flights by private jets registered to MORF